• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Holley And 2 Other Stocks Under $5 Insiders Are Buying

    6/17/24 7:51:24 AM ET
    $HBIO
    $HLLY
    $SYPR
    Biotechnology: Laboratory Analytical Instruments
    Industrials
    Auto Parts:O.E.M.
    Consumer Discretionary
    Get the next $HBIO alert in real time by email

    The Dow Jones index closed lower by around 0.2% on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company’s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

    Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga’s insider transactions platform.

    Harvard Bioscience

    • The Trade: Harvard Bioscience, Inc. (NASDAQ:HBIO) CEO James W Green bought a total of 10,000 shares at an average price of $2.91. To acquire these shares, it cost around $29,100.
    • What's Happening: On May 7, Harvard Bioscience posted weaker-than-expected quarterly sales.
    • What Harvard Bioscience Does: Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development.

    Sypris Solutions

    • The Trade: Sypris Solutions, Inc. (NASDAQ:SYPR) Director Gary L Convis acquired a total of 20,000 shares at an average price of $1.92. To acquire these shares, it cost around $38,400.
    • What's Happening: On June 3, Sypris named Michael D. Sedgwick as Vice President and General Manager of Sypris Electronics, LLC.
    • What Sypris Solutions Does: Sypris Solutions Inc is a USA-based company engaged in providing truck components, oil and gas pipeline components, and aerospace and defense electronics.

    Holley

    • The Trade: Holley Inc. (NYSE:HLLY) Exec. Chairman of the Board Matthew E Rubel acquired a total of 14,493 shares at an average price of $3.39. The insider spent around $49,131 to buy those shares.
    • What's Happening: On June 4, Telsey Advisory Group analyst Joseph Feldman maintained Holley with an Outperform and maintained a $6.5 price target.
    • What Holley Does: Holley Inc is a designer, marketer, and manufacturer of high-performance automotive aftermarket products, featuring a portfolio of iconic brands serving the car and truck industry.

    Check This Out: Wall Street’s Most Accurate Analysts Weigh In On 3 Tech Stocks With Over 3% Dividend Yields

    Get the next $HBIO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HBIO
    $HLLY
    $SYPR

    CompanyDatePrice TargetRatingAnalyst
    Holley Inc.
    $HLLY
    8/8/2025$4.00Hold → Buy
    The Benchmark Company
    Holley Inc.
    $HLLY
    5/9/2025Buy → Hold
    The Benchmark Company
    Harvard Bioscience Inc.
    $HBIO
    4/9/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    Holley Inc.
    $HLLY
    11/11/2024$5.50 → $4.50Outperform
    Telsey Advisory Group
    Holley Inc.
    $HLLY
    8/8/2024$6.50 → $5.50Outperform
    Telsey Advisory Group
    Holley Inc.
    $HLLY
    5/9/2024$9.00 → $6.50Outperform
    Telsey Advisory Group
    Holley Inc.
    $HLLY
    2/20/2024$6.50 → $5.00Overweight → Neutral
    JP Morgan
    Holley Inc.
    $HLLY
    11/15/2023$8.00 → $5.00Hold → Buy
    Jefferies
    More analyst ratings

    $HBIO
    $HLLY
    $SYPR
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Harvard Bioscience Inc.

    SCHEDULE 13G/A - HARVARD BIOSCIENCE INC (0001123494) (Subject)

    2/12/26 11:27:18 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Harvard Bioscience Inc. filed SEC Form 8-K: Results of Operations and Financial Condition

    8-K - HARVARD BIOSCIENCE INC (0001123494) (Filer)

    2/10/26 7:30:26 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form EFFECT filed by Harvard Bioscience Inc.

    EFFECT - HARVARD BIOSCIENCE INC (0001123494) (Filer)

    2/10/26 12:15:27 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $HBIO
    $HLLY
    $SYPR
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Holley Inc. upgraded by The Benchmark Company with a new price target

    The Benchmark Company upgraded Holley Inc. from Hold to Buy and set a new price target of $4.00

    8/8/25 7:56:58 AM ET
    $HLLY
    Auto Parts:O.E.M.
    Consumer Discretionary

    Holley Inc. downgraded by The Benchmark Company

    The Benchmark Company downgraded Holley Inc. from Buy to Hold

    5/9/25 8:42:18 AM ET
    $HLLY
    Auto Parts:O.E.M.
    Consumer Discretionary

    Harvard Biosci downgraded by KeyBanc Capital Markets

    KeyBanc Capital Markets downgraded Harvard Biosci from Overweight to Sector Weight

    4/9/25 8:35:36 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $HBIO
    $HLLY
    $SYPR
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Holley Performance Brands to Release Fourth Quarter and Full Year 2025 Results on March 4, 2026

    BOWLING GREEN, Ky., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Holley Performance Brands (NYSE: HLLY), a leader in automotive aftermarket performance solutions, today announced the date for the release of its fourth quarter and full year 2025 financial results. Fourth Quarter and Full Year 2025 Results        Holley will host a conference call and live webcast on Wednesday, March 4, 2026, at 8:30 am (Eastern Time) to discuss the Company's fourth quarter and full year 2025 financial results. The Company's earnings release and presentation for the fourth quarter and full year 2025 will be issued before the market opens on Wednesday, March 4, 2026, and will be available on the Investor Relations page

    2/18/26 8:35:00 AM ET
    $HLLY
    Auto Parts:O.E.M.
    Consumer Discretionary

    Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

    Reports preliminary fourth quarter revenue in line with guidance, gross margin at high end of guidance, and strong year over year adjusted EBITDA performance Expects year over year revenue growth and mid-to high-single-digit EBITDA growth in 2026Outlines strategy focused on positioning the company as a leader in the growing translational science tools market while expanding consumables revenue and improving operational performance HOLLISTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience"), a global leader in life science research tools, today announced preliminary financial results for the fourth quarter ended Decembe

    2/10/26 7:30:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Harvard Bioscience Announces Strategic Consolidation of Manufacturing Operations to Improve Efficiency and Support Long-Term Growth

    Streamlining production footprint and improving manufacturing efficiency through phased closure of Holliston, MA plant Initiative expected to deliver approximately $3 million in cost savings in 2027 and $4 million in annual cost savings beginning in 2028 while improving throughput and execution HOLLISTON, Mass., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience"), today announced a strategic consolidation of its manufacturing operations designed to enhance operational efficiency, strengthen execution, and accelerate cost-savings efforts. The Company will close its manufacturing facility in Holliston, MA and transition U.S. prod

    1/29/26 4:30:00 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $HBIO
    $HLLY
    $SYPR
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Convis Gary L bought $8,884 worth of shares (5,615 units at $1.58), increasing direct ownership by 1% to 466,242 units (SEC Form 4)

    4 - SYPRIS SOLUTIONS INC (0000864240) (Issuer)

    8/26/24 4:23:46 PM ET
    $SYPR
    Industrial Machinery/Components
    Industrials

    Director Convis Gary L bought $248 worth of shares (155 units at $1.60), increasing direct ownership by 0.03% to 460,627 units (SEC Form 4)

    4 - SYPRIS SOLUTIONS INC (0000864240) (Issuer)

    8/22/24 4:48:07 PM ET
    $SYPR
    Industrial Machinery/Components
    Industrials

    Director Convis Gary L bought $16,664 worth of shares (10,547 units at $1.58), increasing direct ownership by 2% to 460,472 units (SEC Form 4)

    4 - SYPRIS SOLUTIONS INC (0000864240) (Issuer)

    8/21/24 6:14:03 PM ET
    $SYPR
    Industrial Machinery/Components
    Industrials

    $HBIO
    $HLLY
    $SYPR
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Snider William was granted 110,000 shares (SEC Form 4)

    4 - HARVARD BIOSCIENCE INC (0001123494) (Issuer)

    12/30/25 8:48:41 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    SEC Form 3 filed by new insider Snider William

    3 - HARVARD BIOSCIENCE INC (0001123494) (Issuer)

    12/30/25 8:46:35 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    President and CEO Stevenson Matthew covered exercise/tax liability with 178,194 shares, decreasing direct ownership by 6% to 2,901,835 units (SEC Form 4)

    4 - Holley Inc. (0001822928) (Issuer)

    12/29/25 1:53:29 PM ET
    $HLLY
    Auto Parts:O.E.M.
    Consumer Discretionary

    $HBIO
    $HLLY
    $SYPR
    Leadership Updates

    Live Leadership Updates

    View All

    Holley Performance Brands Appoints Del Bohlman as Vice President, Safety & Racing Division

    BOWLING GREEN, Ky., Jan. 20, 2026 (GLOBE NEWSWIRE) -- Holley Performance Brands (NYSE:HLLY), a leader in automotive aftermarket performance solutions, today announced the appointment of Del Bohlman as vice president of its Safety & Racing Division, effective Jan. 1, 2026. Bohlman succeeds Brian Appelgate, who is retiring after a distinguished four-decade career in the performance automotive industry. Bohlman brings more than 20 years of global leadership experience in the powersports and performance sectors, most recently as CEO of Dealer Rocket LLC and previously in senior roles at Bombardier Recreational Products (BRP). At BRP, Bohlman led global services, parts, accessories and garment

    1/20/26 8:30:00 AM ET
    $HLLY
    Auto Parts:O.E.M.
    Consumer Discretionary

    Harvard Bioscience Announces the Successful Completion of Debt Refinancing with Comprehensive Growth Financing Package

    Completes Repayment of Existing Credit Agreement, Extends Debt Maturity, and Enhances Financial FlexibilityBroadOak Partner Bill Snider to Join Board of Directors and Company to Form Advisory Board on Growth and Operating Opportunities  HOLLISTON, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience"), today announced it entered into an agreement with BroadOak Capital Partners (collectively, "BroadOak"), a life-sciences-focused investment and advisory firm, to provide a $40 million credit facility comprised of three term loans, all of which will be funded on December 17, 2025. The proceeds of the facility will be used to ret

    12/17/25 7:30:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Harvard Bioscience Announces Appointment of Stephen DeNelsky to Board of Directors

    HOLLISTON, Mass., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience") today announced the appointment of Stephen DeNelsky to its Board of Directors, effective September 5, 2025. Mr. DeNelsky will also serve on the Board's Nominating and Governance Committee. "We are pleased to announce Steve as the newest member of our Board of Directors at such an important time for Harvard Bioscience," said John Duke, President & CEO. "His knowledge across the verticals we operate in, as well as his expertise in guiding life sciences companies on financial strategy will be invaluable as we move forward." "I'm honored to join the Board and lo

    9/9/25 7:00:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    $HBIO
    $HLLY
    $SYPR
    Financials

    Live finance-specific insights

    View All

    Holley Performance Brands to Release Fourth Quarter and Full Year 2025 Results on March 4, 2026

    BOWLING GREEN, Ky., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Holley Performance Brands (NYSE: HLLY), a leader in automotive aftermarket performance solutions, today announced the date for the release of its fourth quarter and full year 2025 financial results. Fourth Quarter and Full Year 2025 Results        Holley will host a conference call and live webcast on Wednesday, March 4, 2026, at 8:30 am (Eastern Time) to discuss the Company's fourth quarter and full year 2025 financial results. The Company's earnings release and presentation for the fourth quarter and full year 2025 will be issued before the market opens on Wednesday, March 4, 2026, and will be available on the Investor Relations page

    2/18/26 8:35:00 AM ET
    $HLLY
    Auto Parts:O.E.M.
    Consumer Discretionary

    Harvard Bioscience Announces Preliminary Fourth Quarter Financial Results, Positive Outlook for 2026 & Outlines Long-Term Strategic Focus Areas

    Reports preliminary fourth quarter revenue in line with guidance, gross margin at high end of guidance, and strong year over year adjusted EBITDA performance Expects year over year revenue growth and mid-to high-single-digit EBITDA growth in 2026Outlines strategy focused on positioning the company as a leader in the growing translational science tools market while expanding consumables revenue and improving operational performance HOLLISTON, Mass., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (NASDAQ:HBIO) (the "Company" or "Harvard Bioscience"), a global leader in life science research tools, today announced preliminary financial results for the fourth quarter ended Decembe

    2/10/26 7:30:00 AM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Sypris Reports Third Quarter Results

    Orders Rise 65% YTD For Sypris Electronics Strong Demand From Electronic Warfare And Communications Markets Sypris Solutions, Inc. (Nasdaq/GM: SYPR) today reported financial results for its third quarter ended September 28, 2025. HIGHLIGHTS   The Company's third quarter revenue decreased compared to the prior-year quarter primarily due to the near-term impact of tariffs, which reduced demand from certain transportation-related customers and necessitated the conversion of certain shipments from our facility in Mexico to a value-add only sub-maquiladora. Year-to-date orders for Sypris Electronics increased 65% as compared to the prior year comparable period, driving backl

    11/12/25 7:45:00 AM ET
    $SYPR
    Industrial Machinery/Components
    Industrials

    $HBIO
    $HLLY
    $SYPR
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Harvard Bioscience Inc.

    SC 13G/A - HARVARD BIOSCIENCE INC (0001123494) (Subject)

    11/14/24 12:31:23 PM ET
    $HBIO
    Biotechnology: Laboratory Analytical Instruments
    Industrials

    Amendment: SEC Form SC 13G/A filed by Holley Inc.

    SC 13G/A - Holley Inc. (0001822928) (Subject)

    11/13/24 4:05:15 PM ET
    $HLLY
    Auto Parts:O.E.M.
    Consumer Discretionary

    Amendment: SEC Form SC 13G/A filed by Sypris Solutions Inc.

    SC 13G/A - SYPRIS SOLUTIONS INC (0000864240) (Subject)

    11/4/24 2:40:39 PM ET
    $SYPR
    Industrial Machinery/Components
    Industrials